Maxime A. Gallant

2.4k total citations · 1 hit paper
36 papers, 2.0k citations indexed

About

Maxime A. Gallant is a scholar working on Molecular Biology, Pharmacology and Orthopedics and Sports Medicine. According to data from OpenAlex, Maxime A. Gallant has authored 36 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Pharmacology and 11 papers in Orthopedics and Sports Medicine. Recurrent topics in Maxime A. Gallant's work include Inflammatory mediators and NSAID effects (12 papers), Bone health and treatments (10 papers) and Bone health and osteoporosis research (9 papers). Maxime A. Gallant is often cited by papers focused on Inflammatory mediators and NSAID effects (12 papers), Bone health and treatments (10 papers) and Bone health and osteoporosis research (9 papers). Maxime A. Gallant collaborates with scholars based in United States, Canada and United Kingdom. Maxime A. Gallant's co-authors include David B. Burr, Artur J. de Brum‐Fernandes, Jean‐Luc Parent, Joseph M. Wallace, Matthew R. Allen, Drew M. Brown, Marc Labelle, Kathleen M. Metters, Max A. Hammond and Deborah Slipetz and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biomaterials.

In The Last Decade

Maxime A. Gallant

35 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bone remodelling in osteoarthritis

2012 701 citations David B. Burr, Maxime A. Gallant Nature Reviews Rheumatology profile →

Peers

Maxime A. Gallant

RHEUM

PHARM

OSM

SURGE

Mohammed Sharif United Kingdom

Wei Luo China

Chun Zeng China

Huilin Yang China

Shunsuke Uehara Japan

Liangming Zhang China

E.L. Vitters Netherlands

R.A.D. Bunning United Kingdom

S.C. Mastbergen Netherlands

Moroe Beppu Japan

Mohammed Sharif United Kingdom

Maxime A. Gallant

1.3k ×2.0

RHEUM

533 ×0.8

366 ×0.8

PHARM

215 ×0.5

OSM

475 ×1.2

SURGE

Citations per year, relative to Maxime A. Gallant Maxime A. Gallant (= 1×) peers Mohammed Sharif

Countries citing papers authored by Maxime A. Gallant

Since Specialization

Citations

This map shows the geographic impact of Maxime A. Gallant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime A. Gallant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime A. Gallant more than expected).

Fields of papers citing papers by Maxime A. Gallant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime A. Gallant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime A. Gallant. The network helps show where Maxime A. Gallant may publish in the future.

Co-authorship network of co-authors of Maxime A. Gallant

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime A. Gallant. A scholar is included among the top collaborators of Maxime A. Gallant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime A. Gallant. Maxime A. Gallant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gallant, Maxime A., Whitney A. Bullock, Teresita Bellido, et al.. (2025). The development of a collagen-nanoscale hydroxyapatite three-dimensional (3D) in vitro culture system for reproducing osteocyte differentiation and tissue mineralization. Biomaterials. 324. 123451–123451.

Li, Yumei, Jianfeng Xu, Desen Wan, et al.. (2024). Multimodal epigenetic sequencing analysis (MESA) of cell-free DNA for non-invasive colorectal cancer detection. Genome Medicine. 16(1). 9–9. 10 indexed citations

Wright, Christian S., Perla C. Reyes Fernández, William R. Thompson, et al.. (2022). Effects of Dietary Protein Source and Quantity on Bone Morphology and Body Composition Following a High-Protein Weight-Loss Diet in a Rat Model for Postmenopausal Obesity. Nutrients. 14(11). 2262–2262. 2 indexed citations

Gallant, Maxime A., Drew M. Brown, Max A. Hammond, et al.. (2014). Bone cell-independent benefits of raloxifene on the skeleton: A novel mechanism for improving bone material properties. Bone. 61. 191–200. 77 indexed citations

Gallant, Kathleen M. Hill, et al.. (2014). Raloxifene Prevents Skeletal Fragility in Adult Female Zucker Diabetic Sprague-Dawley Rats. PLoS ONE. 9(9). e108262–e108262. 15 indexed citations

Aref, Mohammad W., Maxime A. Gallant, Jason M. Organ, et al.. (2013). In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6months of treatment in skeletally mature beagle dogs. Bone. 56(2). 449–453. 38 indexed citations

Yassen, Ghaeth H., Tien‐Min Gabriel Chu, Maxime A. Gallant, et al.. (2013). A novel approach to evaluate the effect of medicaments used in endodontic regeneration on root canal surface indentation. Clinical Oral Investigations. 18(6). 1569–1575. 15 indexed citations

Hammond, Max A., Maxime A. Gallant, David B. Burr, & Joseph M. Wallace. (2013). Nanoscale changes in collagen are reflected in physical and mechanical properties of bone at the microscale in diabetic rats. Bone. 60. 26–32. 76 indexed citations

Gallant, Maxime A., et al.. (2013). Multiscale analysis of morphology and mechanics in tail tendon from the ZDSD rat model of type 2 diabetes. Journal of Biomechanics. 47(3). 681–686. 27 indexed citations

10.

Labrecque, Pascale, et al.. (2013). Inverse Agonist and Pharmacochaperone Properties of MK-0524 on the Prostanoid DP1 Receptor. PLoS ONE. 8(6). e65767–e65767. 18 indexed citations

11.

Burr, David B. & Maxime A. Gallant. (2012). Bone remodelling in osteoarthritis. Nature Reviews Rheumatology. 8(11). 665–673. 701 indexed citations breakdown →

12.

Turek, John, Frank H. Ebetino, Mark W. Lundy, et al.. (2012). Bisphosphonate Binding Affinity Affects Drug Distribution in Both Intracortical and Trabecular Bone of Rabbits. Calcified Tissue International. 90(3). 202–210. 33 indexed citations

13.

Gallant, Maxime A., Drew M. Brown, Jason M. Organ, Matthew R. Allen, & David B. Burr. (2012). Reference-point indentation correlates with bone toughness assessed using whole-bone traditional mechanical testing. Bone. 53(1). 301–305. 103 indexed citations

14.

Gallant, Maxime A., Keith W. Condon, Nicole C. Walsh, et al.. (2011). Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway. Arthritis & Rheumatism. 64(5). 1540–1550. 124 indexed citations

15.

Parent, Audrey V., Christian Iorio‐Morin, Marie‐Claude Lépine, et al.. (2010). ANKRD13C Acts as a Molecular Chaperone for G Protein-coupled Receptors. Journal of Biological Chemistry. 285(52). 40838–40851. 19 indexed citations

16.

Gallant, Maxime A., Hugues Allard‐Chamard, Christian Iorio‐Morin, et al.. (2010). An Interaction between L-prostaglandin D Synthase and Arrestin Increases PGD2 Production. Journal of Biological Chemistry. 286(4). 2696–2706. 10 indexed citations

17.

Gallant, Maxime A., Estelle Chamoux, Martine Bisson, et al.. (2010). Increased Concentrations of Prostaglandin D₂During Post-Fracture Bone Remodeling. The Journal of Rheumatology. 37(3). 644–649. 16 indexed citations

18.

Parent, Audrey V., et al.. (2009). Characterization of C-terminal tail determinants involved in CRTH2 receptor trafficking: Identification of a recycling motif. European Journal of Pharmacology. 630(1-3). 10–18. 13 indexed citations

19.

Gallant, Maxime A., Deborah Slipetz, Moulay Driss Rochdi, et al.. (2006). Differential regulation of the signaling and trafficking of the two prostaglandin D2 receptors, prostanoid DP receptor and CRTH2. European Journal of Pharmacology. 557(2-3). 115–123. 34 indexed citations

20.

Machwate, M., Satoru Harada, Chih‐Tai Leu, et al.. (2001). Prostaglandin Receptor EP4 Mediates the Bone Anabolic Effects of PGE2. Molecular Pharmacology. 60(1). 36–41. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact